Directory → Immunotropona funds → Immunomodulators → Ronkoleikin
This page is translated automatically with a help of Google Translate
RonkoleikinSee also Interleukin-2 recombinant humanRoman nameRoncoleukinum #The composition and the form of1 USD with liofilizirovannam powder preparation infuzing solution containing recombinant interleikina-2 0.25, 0.5 or 1 mg (250,000, 500,000 or 1 million IU respectively); in a cardboard bundle five vials (complete with a knife ampulnam).CharacteristicsStructural and functional analogue of the endogenous human interleikina-2.Of drugsImmunomodulirutee. Fills deficit endogenous interleikina-2 and reproduces its effects. Working with the receptors, induces growth, differentiation and proliferatiou air and V-limfozitov, monocytes, macrophages, oligodendroglialnah cells epidermalnah Langergansa cells. It is a matter of education лимфокинактивированн ых blood, activates �пухоль-инфильтрирующ ие cells. Does zitoliticescuu activity of natural killers and cytotoxic lymphocytes increases the resistance of cells to programmed cell death-apoptozu. Provides immune protection : antibakterialnuyu, protivovirusnuu and protivogribkovu, protivoopujolevu.IndicationsSeptic condition associated immunosuppression (sepsis trauma, surgery, akushersko-ginekologicaki, Burns, Wound etc.), malignant neoplasms, including kidney cancer.Pregnancy and lactationContraindicated in pregnancy.ContraindicationsГиперчувствительност ь to any component of the drug, allergy against yeasts, auto and heavy cardiovascular disease, pregnancy.Side-EffectsGrippopodobnyy syndrome (short runs, hyperthermia).Specific guidanceThe homemade solution content capsules slowly dissolve in 1.5-2 ml sodium chloride injection and received solution carrying 400 ml izotoniceski solution of sodium chloride. To prevent the loss of biological activity of sodium, depending on the starting dose injection (1 mg, 0.5 mg or 0.25 mg) added 10% solution of whey human albumin (8, 6 or 4 ml respectively). During preparations solution should avoid flushing.PrecautionsTreatment is carried out under medical supervision.Dosing and AdministrationIn / in, drip at the rate of approximately 1-2 ml / min (within 4-6 h), s / c, vnutripolostno, Mestno.pri sepsise, infectious and гнойно-воспалительны�� Diseases : 1-3 in the 0.5-1 mg intermittently 1-3 Dna.pri kidney cancer and other malignant tumors : 1 mg three times a week to / drip in the 1st and 4th week and 0.5 mg three times a week to / drip in the second and third weeks of treatment.Storage conditionspor.liof.d / inf. : List B. In the dark place at a temperature of -4 to -20 ° CShelf lifepor.liof.d / inf. : 2 grams. |
All products of this group |

